Bayer Aktiengesellschaft

Matthias Herboth

Alfred Von Schuckmann

Heiko Herold

Peter Serno

Peter Kurka

Axel Wollenschlager

Reiner Diederich

Roland Kleissendorf

Ahmed Hegazy

The invention relates to stable liposomal injectable formulations for lipophilic, poorly soluble active compounds, in the form of liposomes which are stabilized by short-chain fatty acids, in particular for active compounds from the dihydropyridines group.

Injectable liposomal pharmaceutical preparations

The device for inhalation of a powdery, pharmacologically active drug consists of a supply container (3) for the drug (4), a manually actuated metering unit for providing a portioned-off quantity of inhalation substance which is picked up by the air current drawn in during inhalation and is swirled, an air inlet channel (9), a swirl chamber (W), and a connection channel (8) between the swirl cheer (W) and the metering unit, as well as a mouthpiece channel issuing from the swirl chamber (W). The metering unit here consists of a metering drum (D) which has, in its interior (5), a supply container (3) for the drug. Furthermore, the air inlet channel (9) and the connection channel (8) are arranged in such a way that they run towards each other in a V-shape. During a metering procedure, a portioned-off quantity of drug for inhalation present in the shape of a dome is provided in each case at the apex of the two air channels (8) and (9) running towards each other in a V-shape.

Device for inhalation

Growing community of inventors

Leverkusen, Germany

Matthias Herboth